Abstract
We report the immunologic and virologic response of iron deficiency anemia in two cases of human immunodeficiency virus (HIV)-infected individuals. The findings of this report suggest that caution be exercised in prescribing iron supplements to HIV-infected patients. The treatment of iron deficiency anemia should be combined with antiretroviral agents in people living with HIV/AIDS to avoid adverse immunologic and virologic consequences.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beisel W. R. Single nutrients and immunity. Am J Clin Nutr. 1982 Feb;35(2 Suppl):417–468. doi: 10.1093/ajcn/35.2.417. [DOI] [PubMed] [Google Scholar]
- Delanghe J. R., Langlois M. R., Boelaert J. R., Van Acker J., Van Wanzeele F., van der Groen G., Hemmer R., Verhofstede C., De Buyzere M., De Bacquer D. Haptoglobin polymorphism, iron metabolism and mortality in HIV infection. AIDS. 1998 Jun 18;12(9):1027–1032. [PubMed] [Google Scholar]
- Dhople A. M., Ibanez M. A., Poirier T. C. Role of iron in the pathogenesis of Mycobacterium avium infection in mice. Microbios. 1996;87(351):77–87. [PubMed] [Google Scholar]
- Herzenberg L. A., De Rosa S. C., Dubs J. G., Roederer M., Anderson M. T., Ela S. W., Deresinski S. C., Herzenberg L. A. Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1967–1972. doi: 10.1073/pnas.94.5.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Igarashi T., Brown C. R., Endo Y., Buckler-White A., Plishka R., Bischofberger N., Hirsch V., Martin M. A. Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans. Proc Natl Acad Sci U S A. 2001 Jan 2;98(2):658–663. doi: 10.1073/pnas.021551798. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lederman H. M., Cohen A., Lee J. W., Freedman M. H., Gelfand E. W. Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation. Blood. 1984 Sep;64(3):748–753. [PubMed] [Google Scholar]
- Mencacci A., Cenci E., Boelaert J. R., Bucci P., Mosci P., Fè d'Ostiani C., Bistoni F., Romani L. Iron overload alters innate and T helper cell responses to Candida albicans in mice. J Infect Dis. 1997 Jun;175(6):1467–1476. doi: 10.1086/516481. [DOI] [PubMed] [Google Scholar]
- Monroe J. A., Godwin J. H., Godwin T. A. HIV/AIDS case histories: iron deficiency anemia and altered iron metabolism in HIV infection. AIDS Patient Care STDS. 2000 Dec;14(12):667–669. doi: 10.1089/10872910050206595. [DOI] [PubMed] [Google Scholar]
- Murray M. J., Murray A. B., Murray M. B., Murray C. J. The adverse effect of iron repletion on the course of certain infections. Br Med J. 1978 Oct 21;2(6145):1113–1115. doi: 10.1136/bmj.2.6145.1113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sappey C., Boelaert J. R., Legrand-Poels S., Forceille C., Favier A., Piette J. Iron chelation decreases NF-kappa B and HIV type 1 activation due to oxidative stress. AIDS Res Hum Retroviruses. 1995 Sep;11(9):1049–1061. doi: 10.1089/aid.1995.11.1049. [DOI] [PubMed] [Google Scholar]
- Weinberg G. A. Iron chelators as therapeutic agents against Pneumocystis carinii. Antimicrob Agents Chemother. 1994 May;38(5):997–1003. doi: 10.1128/aac.38.5.997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- de Monyé C., Karcher D. S., Boelaert J. R., Gordeuk V. R. Bone marrow macrophage iron grade and survival of HIV-seropositive patients. AIDS. 1999 Feb 25;13(3):375–380. doi: 10.1097/00002030-199902250-00010. [DOI] [PubMed] [Google Scholar]